DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

37.40 -0.09 (-0.24%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SRPT $37.40 -0.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.49
Previous Close $37.49
Daily Range $37.04 - $38.19
52-Week Range $11.33 - $41.97
Market Cap $1.7B
P/E Ratio -8.82
Dividend (Yield) $0.00 (0.0%)
Volume 1,007,848
Average Daily Volume 2,109,663
Current FY EPS -$4.88




Drug Makers

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website:

News & Commentary

Sarepta Therapeutics: Discretion Is the Better Part of Valor

Sarepta Therapeutics has been on an incredible bull run because of its experimental DMD therapy eteplirsen. Shareholders nevertheless need to consider taking one of two simple steps right now to protect themselves in case things reverse course in a hurry.

BioMarin's (BMRN) Kyndrisa Fails to Impress FDA Panel

BioMarin's Duchenne Drug is Done, Sarepta Survives But Faces Challenge

BioMarin FDA Panel Live Blog

BioMarin Down on FDA's Briefing Document on Kyndrisa

BioMarin's DMD Drug Faces Obstacles Tomorrow

An FDA advisory committee will consider the company's therapy for Duchenne muscular dystrophy and its conclusions could impact competitor Sarepta Therapeutics.

Monday's ETF Movers: XBI, ILF

Sarepta Will Take Flight When Biomarin Taxis Off The Runway

Bezek's Daily Briefing - Sarepta Soars; My Take On Biotech

6 BioHealth Movers That Now Cannot Be Ignored

See More SRPT News...

SRPT's Top Competitors

SRPT $37.40 (-0.24%)
Current stock: SRPT
AMGN $163.52 (-0.26%)
Current stock: AMGN
GILD $108.00 (0.20%)
Current stock: GILD
BIIB $293.21 (0.31%)
Current stock: BIIB